Virus News and Research

Latest Virus News and Research

Alzheimer's disease increases a threefold risk of contracting severe COVID-19 and death

Neurodegenerative disorders that cause dementia increase the risk of contracting severe COVID-19 and dying from the disease.

3 Jun 2021

Could a green tea compound combat SARS-CoV-2?

Researchers recently published an article that reviewed the mechanisms by which EGCG could inhibit SARS-CoV-2 infection and the various syndromes caused by COVID-19.

3 Jun 2021

Study explores COVID-19 vaccine beliefs and behaviors among college students

A recent study conducted by researchers at Pennsylvania State University in the US explored the beliefs and attitudes of students about vaccination in general and the COVID-19 vaccines in particular.

3 Jun 2021

Patients with obesity at greater risk of developing long-term complications of COVID-19

A Cleveland Clinic study shows that survivors of COVID-19 who have moderate or severe obesity may have a greater risk of experiencing long-term consequences of the disease, compared with patients who do not have obesity.

3 Jun 2021

Scientists identify many existing drugs with antiviral activity against coronavirus

Mining the world's most comprehensive drug repurposing collection for COVID-19 therapies, scientists have identified 90 existing drugs or drug candidates with antiviral activity against the coronavirus that's driving the ongoing global pandemic.

3 Jun 2021

How can nanomaterials help in the fight against COVID-19?

Researchers have reviewed different types of nanomaterials and how they can be used for the detection, prevention, and treatment of coronavirus disease 2019 (COVID-19).

3 Jun 2021

Researchers develop rapid antibody screening method for novel COVID-19 therapeutics development

New research undertaken by researchers in the USA describes two parallel but distinct in vivo approaches for the accelerated discovery of antibodies targeting SARS-CoV-2 spike protein.

3 Jun 2021

How bacterial cells have been engineered to produce virus-resistant synthetic polymers

A recent Science paper discusses the utilization of a previously reported synthetic Escherichia coli to produce virus-resistant synthetic polymers.

3 Jun 2021

Known pharmaceutical compounds could provide new therapies for COVID-19

After screening over 12,000 existing treatments, researchers have found many promising antiviral compounds that could treat COVID-19.

3 Jun 2021

Study compares Pfizer and Moderna mRNA vaccine-elicited response to SARS-CoV-2 variants

A new study has been published on the bioRxiv preprint server which focuses on the correlation between the vaccine-triggered Immunoglobulin G (IgG) levels and neutralization titers against SARS-CoV-2 variants. Further, neutralization activities against the variants (B.1.1.7, B.1.525, and B.1.351), using Pfizer or Moderna vaccine, sera were assessed.

3 Jun 2021

Scientists assess the filtration efficacy of 227 models of face masks sold in Brazil

The novel coronavirus is transmitted mainly via inhalation of saliva droplets or respiratory secretions suspended in air, so that face covering and social distancing are the most effective ways to prevent COVID-19 until enough vaccines are available for all.

3 Jun 2021

SARS-CoV-2 exploits metal-dependent mechanism to evade immune surveillance

Scientists from The University of Texas Health Science Center at San Antonio have discovered a mechanism by which SARS-CoV-2 exploits changes in metal ion concentrations to disguise itself in the body. Varying concentrations of metal ions -- positively charged atoms such as magnesium, manganese and calcium -- are observed in hospitalized COVID-19 patients.

3 Jun 2021

Researchers detect Zika virus RNA in free-ranging African bats

A team of Colorado State University scientists, led by veterinary postdoctoral fellow Dr. Anna Fagre, has detected Zika virus RNA in free-ranging African bats. RNA, or ribonucleic acid, is a molecule that plays a central role in the function of genes.

3 Jun 2021

Centivax and US Naval Medical Research Center to begin Phase I clinical trial of antibody therapeutics

Centivax Inc. announced today that it has entered into a strategic partnership with the U.S. Naval Medical Research Center (NMRC) for Phase I clinical development of Centi-B9, Centivax's SARS-CoV-2 broad-spectrum injectable antibody therapeutic and prophylactic.

3 Jun 2021

New survey highlights key role of ECT for treating severe depression, other conditions

When the COVID-19 pandemic arrived in North America in March 2020, health care facilities stopped providing all but "essential" care, to reduce infection risks and preserve protective gear known as PPE.

3 Jun 2021

Study could help scientists, policymakers communicate about zoonotic diseases

A new study from North Carolina State University found that certain types of messages could influence how people perceive information about the spread of diseases from wildlife to humans.

3 Jun 2021

Single mutation to bat virus spike protein allows cell entry using human ACE2

In a paper recently uploaded to the preprint server bioRxiv by Kirchhoff et al. (May 31st, 2021) it is demonstrated that a single mutation to the RaTG13 spike protein results in significantly greater affinity towards the human receptor, indicating that the presence of a positively charged amino group at this position better facilitates interaction with the human ACE2 receptor, and helping to identify other viruses with zoonotic potential.

3 Jun 2021

Virus News and Research

Latest Virus News and Research

Alzheimer's disease increases a threefold risk of contracting severe COVID-19 and death

Could a green tea compound combat SARS-CoV-2?

Study explores COVID-19 vaccine beliefs and behaviors among college students

Patients with obesity at greater risk of developing long-term complications of COVID-19

Scientists identify many existing drugs with antiviral activity against coronavirus

How can nanomaterials help in the fight against COVID-19?

Researchers develop rapid antibody screening method for novel COVID-19 therapeutics development

How bacterial cells have been engineered to produce virus-resistant synthetic polymers

Known pharmaceutical compounds could provide new therapies for COVID-19

Study compares Pfizer and Moderna mRNA vaccine-elicited response to SARS-CoV-2 variants

Scientists assess the filtration efficacy of 227 models of face masks sold in Brazil

SARS-CoV-2 exploits metal-dependent mechanism to evade immune surveillance

Researchers detect Zika virus RNA in free-ranging African bats

Centivax and US Naval Medical Research Center to begin Phase I clinical trial of antibody therapeutics

New survey highlights key role of ECT for treating severe depression, other conditions

Study could help scientists, policymakers communicate about zoonotic diseases

Single mutation to bat virus spike protein allows cell entry using human ACE2

Nanopore sequencing contradicts human genome integration of SARS-CoV-2

Predictors of COVID vaccination uptake in the U.S.

Long COVID patients at higher risk of small airway disease

A new way of characterising biomolecules eBook

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Newsletters you may be interested in